Who owns Adverum Biotechnologies, Inc.?
- CUSIP Number: 00773u207
Tip: Access positions for across all investors
Analyze quarterly positions in Adverum Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adverum Biotechnologies stock
Who bought or sold Adverum Biotechnologies, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| VR Adviser | 1.6M | $22M | 100% | Mar 2024 |
|
| Vivo Capital | 1.5M | $21M | 100% | Mar 2024 |
|
| Logos Global Management | 1.5M | $21M | 100% | Mar 2024 |
|
| Vanguard Group | 907k | $13M | 100% | Mar 2024 |
|
| FMR | 901k | $13M | 100% | Mar 2024 |
|
| BML Capital Management | 833k | $12M | 100% | Mar 2024 |
|
| Franklin Resources | 676k | $9.6M | 100% | Mar 2024 |
|
| Commodore Capital | 657k | $9.3M | 100% | Mar 2024 |
|
| Morgan Stanley | 562k | $7.9M | 100% | Mar 2024 |
|
| 5AM Venture Management | 542k | $7.7M | 100% | Mar 2024 |
|
| Laurion Capital Management | 439k | $6.2M | 100% | Mar 2024 |
|
| Assenagon Asset Management | 359k | $5.1M | 100% | Mar 2024 |
|
| BlackRock | 317k | $4.5M | 100% | Mar 2024 |
|
| Samsara BioCapital | 292k | $4.1M | 100% | Mar 2024 |
|
| Millennium Management | 249k | $3.5M | 100% | Mar 2024 |
|
| Geode Capital Management | 194k | $2.7M | 100% | Mar 2024 |
|
| Bank of America Corporation | 166k | $2.3M | 100% | Mar 2024 |
|
| AIGH Capital Management | 163k | $2.3M | 100% | Mar 2024 |
|
| Marshall Wace | 134k | $1.9M | 100% | Mar 2024 |
|
| Picton Mahoney Asset Management | 124k | $1.8M | 100% | Mar 2024 |
|
| Barclays | 53k | $755k | 100% | Mar 2024 |
|
| Citigroup | 53k | $744k | 100% | Mar 2024 |
|
| Newtyn Management | 46k | $653k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 42k | $589k | 100% | Mar 2024 |
|
| Northern Trust | 37k | $520k | 100% | Mar 2024 |
|
| Marathon Trading Investment Management | 28k | $401k | 100% | Mar 2024 |
|
| Squarepoint Ops | 27k | $384k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 27k | $375k | 100% | Mar 2024 |
|
| Shay Capital | 23k | $331k | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 16k | $232k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 16k | $229k | 100% | Mar 2024 |
|
| Cantor Fitzgerald, L. P. | 15k | $218k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 14k | $201k | 100% | Mar 2024 |
|
| Susquehanna International | 12k | $170k | 100% | Mar 2024 |
|
| Two Sigma Investments | 12k | $167k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 11k | $152k | 100% | Mar 2024 |
|
| Point72 Asia | 9.3k | $131k | 100% | Mar 2024 |
|
| Group One Trading | 9.3k | $131k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 8.5k | $120k | 100% | Mar 2024 |
|
| Acadian Asset Management | 2.9k | $41k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 2.8k | $40k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 2.1k | $29k | 100% | Mar 2024 |
|
| Tower Research Capital | 1.0k | $14k | 100% | Mar 2024 |
|
| UBS Group | 932.00 | $13k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 293.00 | $4.1k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 142.00 | $2.0k | 100% | Mar 2024 |
|
| Parallel Advisors | 50.00 | $707.000000 | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 38.00 | $537.000800 | 100% | Mar 2024 |
|
| GHP Investment Advisors | 20.00 | $283.000000 | 100% | Mar 2024 |
|
| Royal Bank of Canada | 11.00 | $0 | 100% | Mar 2024 |
|
| Hanson McClain Advisors | 2.00 | $29.000000 | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 2.00 | $28.000000 | 100% | Mar 2024 |
|